Immunogenomic classification of colorectal cancer and therapeutic implications

Jessica Roelands, Peter J.K. Kuppen, Louis Vermeulen, Cristina Maccalli, Julie Decock, Ena Wang, Francesco M. Marincola, Davide Bedognetti, Wouter R. Hendrickx

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, antitumor orientation are proposed per CMS.

Original languageEnglish
Article number2229
JournalInternational Journal of Molecular Sciences
Volume18
Issue number10
DOIs
Publication statusPublished - 24 Oct 2017

Fingerprint

Immune system
immune systems
Colorectal Neoplasms
phenotype
cancer
Chemotherapy
Immune System
Radiotherapy
Phenotype
Tumors
Tumor Microenvironment
chemotherapy
progressions
escape
radiation therapy
therapy
Therapeutics
tumors
Drug Therapy
shift

Keywords

  • Colorectal cancer
  • Combination therapy
  • Consensus molecular subtypes
  • Immune contexture
  • Immunologic constant of rejection
  • Immunotherapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Immunogenomic classification of colorectal cancer and therapeutic implications. / Roelands, Jessica; Kuppen, Peter J.K.; Vermeulen, Louis; Maccalli, Cristina; Decock, Julie; Wang, Ena; Marincola, Francesco M.; Bedognetti, Davide; Hendrickx, Wouter R.

In: International Journal of Molecular Sciences, Vol. 18, No. 10, 2229, 24.10.2017.

Research output: Contribution to journalReview article

@article{ba42fbe9d7e943d38519dc2abd19822d,
title = "Immunogenomic classification of colorectal cancer and therapeutic implications",
abstract = "The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, antitumor orientation are proposed per CMS.",
keywords = "Colorectal cancer, Combination therapy, Consensus molecular subtypes, Immune contexture, Immunologic constant of rejection, Immunotherapy, Tumor microenvironment",
author = "Jessica Roelands and Kuppen, {Peter J.K.} and Louis Vermeulen and Cristina Maccalli and Julie Decock and Ena Wang and Marincola, {Francesco M.} and Davide Bedognetti and Hendrickx, {Wouter R.}",
year = "2017",
month = "10",
day = "24",
doi = "10.3390/ijms18102229",
language = "English",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - Immunogenomic classification of colorectal cancer and therapeutic implications

AU - Roelands, Jessica

AU - Kuppen, Peter J.K.

AU - Vermeulen, Louis

AU - Maccalli, Cristina

AU - Decock, Julie

AU - Wang, Ena

AU - Marincola, Francesco M.

AU - Bedognetti, Davide

AU - Hendrickx, Wouter R.

PY - 2017/10/24

Y1 - 2017/10/24

N2 - The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, antitumor orientation are proposed per CMS.

AB - The immune system has a substantial effect on colorectal cancer (CRC) progression. Additionally, the response to immunotherapeutics and conventional treatment options (e.g., chemotherapy, radiotherapy and targeted therapies) is influenced by the immune system. The molecular characterization of colorectal cancer (CRC) has led to the identification of favorable and unfavorable immunological attributes linked to clinical outcome. With the definition of consensus molecular subtypes (CMSs) based on transcriptomic profiles, multiple characteristics have been proposed to be responsible for the development of the tumor immune microenvironment and corresponding mechanisms of immune escape. In this review, a detailed description of proposed immune phenotypes as well as their interaction with different therapeutic modalities will be provided. Finally, possible strategies to shift the CRC immune phenotype towards a reactive, antitumor orientation are proposed per CMS.

KW - Colorectal cancer

KW - Combination therapy

KW - Consensus molecular subtypes

KW - Immune contexture

KW - Immunologic constant of rejection

KW - Immunotherapy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85032435390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032435390&partnerID=8YFLogxK

U2 - 10.3390/ijms18102229

DO - 10.3390/ijms18102229

M3 - Review article

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

M1 - 2229

ER -